Xiao-bo Du
Impact in
- Drug Discovery top 5%
- Radiation top 2%
- Advanced Radiotherapy Techniques
Papers in
- Radiation 17
- Advanced Radiotherapy Techniques 15
-
- Radiation Therapy and Dosimetry 8
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Binwei Lin (25 shared papers)Tangzhi Dai (14 shared papers)Gang Ling Feng (13 shared papers)Feng Gao (8 shared papers)Dai Wu (5 shared papers)Yiwei Yang (5 shared papers)Wen‐xiu Yao (3 shared papers)Ke Xie (2 shared papers)
- Journals
- Frontiers in Oncology (12 papers)Medicine (9 papers)Radiation Oncology (5 papers)PLoS ONE (5 papers)Radiotherapy and Oncology (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiao-bo Du
92 papers receiving 1.9k citations
Xiao-bo Du's Hit Papers
Peers
Comparison fields: 5 of 114
- Drug Discovery 14
- Radiation 238
- Otorhinolaryngology 114
- Biochemistry 92
- Pulmonary and Respiratory Medicine 398
Countries citing papers authored by Xiao-bo Du
This map shows the geographic impact of Xiao-bo Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-bo Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-bo Du more than expected).
Fields of papers citing papers by Xiao-bo Du
This network shows the impact of papers produced by Xiao-bo Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-bo Du. The network helps show where Xiao-bo Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-bo Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 227 | |
| 2 | 2011 | 146 | |
| 3 | FLASH Radiotherapy: History and Future Hit paper breakdown → | 2021 | 140 |
| 4 | 2021 | 119 | |
| 5 | Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant Hit paper breakdown → | 2024 | 119 |
| 6 | 2007 | 108 | |
| 7 | 2017 | 103 | |
| 8 | 2017 | 83 | |
| 9 | 2022 | 47 | |
| 10 | 2021 | 43 | |
| 11 | 2020 | 31 | |
| 12 | 2009 | 30 | |
| 13 | 2022 | 30 | |
| 14 | 2023 | 26 | |
| 15 | 1998 | 25 | |
| 16 | 2008 | 24 | |
| 17 | 2011 | 22 | |
| 18 | 2017 | 22 | |
| 19 | 2012 | 21 | |
| 20 | 2019 | 21 |
About Xiao-bo Du
Xiao-bo Du is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Oncology, having authored 107 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (15 papers), Esophageal Cancer Research and Treatment (11 papers), Radiation Therapy and Dosimetry (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Effects of Radiation Exposure (5 papers), Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Women's cancer prevention and management (4 papers). The work is most often cited by research in Drug Discovery (14 citations), Radiation (238 citations), Otorhinolaryngology (114 citations), Biochemistry (92 citations) and Pulmonary and Respiratory Medicine (398 citations). Xiao-bo Du has collaborated with scholars based in China and United States. Frequent co-authors include Binwei Lin, Tangzhi Dai, Gang Ling Feng, Feng Gao, Dai Wu, Yiwei Yang, Wen‐xiu Yao, Ke Xie, Wenxiu Yao and Guangli Yang. Their work appears in journals such as Frontiers in Oncology, Medicine, Radiation Oncology, PLoS ONE and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.